<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.0?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Transfusion</journal-id>
      <journal-id journal-id-type="publisher-id">trf</journal-id>
      <journal-title-group>
        <journal-title>Transfusion</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0041-1132</issn>
      <issn pub-type="epub">1537-2995</issn>
      <publisher>
        <publisher-name>Blackwell Publishing Inc</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3084503</article-id>
      <article-id pub-id-type="pmid">20804530</article-id>
      <article-id pub-id-type="doi">10.1111/j.1537-2995.2010.02862.x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Immunohematology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Landau</surname>
            <given-names>Meytal</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosenberg</surname>
            <given-names>Nurit</given-names>
          </name>
        </contrib>
        <aff>
          <institution>Amalia Biron Research Institute of Thrombosis and Hemostasis, Chaim Sheba Medical Center, Tel-Hashomer; and the Sackler Faculty of Medicine, Tel-Aviv University</institution>
          <addr-line>Tel-Aviv, Israel</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><italic>Address reprint requests to:</italic> Nurit Rosenberg, PhD, Amalia Biron Research Institute of Thrombosis and Homeostasis, Chaim Sheba Medical Center, Tel-Hashomer, Israel 52621; e-mail: <email>nuritros@sheba.health.gov.il</email></corresp>
        <fn>
          <p>Re-use of this article is permitted in accordance with the Terms and Conditions set out at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms">http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms</ext-link></p>
        </fn>
        <fn id="fn1">
          <label>*</label>
          <p>current location: Department of Chemistry and Biochemistry and the UCLA-DOE Institute for genomics and Proteomics, University of California, Los Angeles, CA, USA.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>51</volume>
      <issue>3</issue>
      <fpage>558</fpage>
      <lpage>569</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>04</day>
          <month>7</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>7</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011 AABB</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>BACKGROUND:</title>
          <p>Human platelet antigens (HPAs) are polymorphisms in platelet membrane glycoproteins (GPs) that can stimulate production of alloantibodies once exposed to foreign platelets (PLTs) with different HPAs. These antibodies can cause neonatal alloimmune thrombocytopenia, posttransfusion purpura, and PLT transfusion refractoriness. Most HPAs are localized on the main PLT receptors: 1) integrin &#x3B1;IIb&#x3B2;3, known as the fibrinogen receptor; 2) the GPIb-IX-V complex that functions as the receptor for von Willebrand factor; and 3) integrin &#x3B1;2&#x3B2;1, which functions as the collagen receptor.</p>
        </sec>
        <sec>
          <title>STUDY DESIGN AND METHODS:</title>
          <p>We analyzed the structural location and the evolutionary conservation of the residues associated with the HPAs to characterize the features that induce immunologic responses but do not cause inherited diseases.</p>
        </sec>
        <sec>
          <title>RESULTS:</title>
          <p>We found that all HPAs reside in positions located on the protein surface, apart from the ligand-binding site, and are evolutionary variable.</p>
        </sec>
        <sec>
          <title>CONCLUSION:</title>
          <p>Disease-causing mutations often reside in highly conserved and buried positions. In contrast, the HPAs affect residues on the protein surface that were not conserved throughout evolution; this explains their naive effect on the protein function. Nonetheless, the HPAs involve substitutions of solvent-exposed positions that lead to altered interfaces on the surface of the protein and might present epitopes foreign to the immune system.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Polymorphisms in platelet (PLT) membrane glycoproteins (GPs) are responsible for alloantibody production upon exposure to PLTs with different human PLT antigens (HPA). These antibodies can cause neonatal alloimmune thrombocytopenia (NAIT), posttransfusion purpura, or PLT transfusion refractoriness after exposure to unmatched PLTs. The molecular basis of the 24 serologically defined antigens had been resolved<xref ref-type="bibr" rid="b1">1</xref> and found to be a single-nucleotide polymorphism (SNP) resulting in an amino acid substitution in 23 of 24 antigens: 12 HPAs are grouped in six biallelic systems (HPA-1 to -5 and -15) in which alloantibodies against both the common (designated a) and the rare (designated b) alleles were observed. For the rest, only alloantibodies against the rare allele have been detected. The only non-SNP is HPA-14bw, an in-frame triplet deletion coding for one amino acid (&#x3B2;3-Lys611).<xref ref-type="bibr" rid="b2">2</xref> Overall, there are 17 different HPAs. A nomenclature was devised by the International Society of Blood Transfusion and the International Society of Thrombosis and Haemostasis (see <xref ref-type="table" rid="tbl1">Table 1</xref>).</p>
    <table-wrap id="tbl1" position="float">
      <label>TABLE 1</label>
      <caption>
        <p>
          <bold>Data of the HPAs</bold>
        </p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">HPA (frequency<xref ref-type="table-fn" rid="tf1-1">*</xref>)</th>
            <th align="center" rowspan="1" colspan="1">Gene</th>
            <th align="center" rowspan="1" colspan="1">SNP</th>
            <th align="center" rowspan="1" colspan="1">Amino acid</th>
            <th align="center" rowspan="1" colspan="1">Domain</th>
            <th align="center" rowspan="1" colspan="1">Residue's SASA</th>
            <th align="center" rowspan="1" colspan="1">Secondary structure</th>
            <th align="center" rowspan="1" colspan="1">Evolutionary conservation</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">1(0.15)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">176 T&gt;C</td>
            <td align="center" rowspan="1" colspan="1">Leu33Pro Leu33Val</td>
            <td align="center" rowspan="1" colspan="1">PSI</td>
            <td align="center" rowspan="1" colspan="1">98% (3FCS)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">175 C&gt;G</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">100% (3FCU)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">2(0.07)</td>
            <td align="center" rowspan="1" colspan="1">GPIb&#x3B1;</td>
            <td align="center" rowspan="1" colspan="1">482 C&gt;T</td>
            <td align="center" rowspan="1" colspan="1">Thr145Met</td>
            <td align="center" rowspan="1" colspan="1">LRR</td>
            <td align="center" rowspan="1" colspan="1">67% (1SQ0)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">3 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">3(0.39)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;IIb</td>
            <td align="center" rowspan="1" colspan="1">2621 T&gt;G</td>
            <td align="center" rowspan="1" colspan="1">Ile843Ser</td>
            <td align="center" rowspan="1" colspan="1">Calf2</td>
            <td align="center" rowspan="1" colspan="1">Disordered region (3FCS)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">2 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">4(0.01<xref ref-type="table-fn" rid="tf1-2">&#x2020;</xref>)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">506 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Arg143Gln</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2; A</td>
            <td align="center" rowspan="1" colspan="1">62% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;-Helix</td>
            <td align="center" rowspan="1" colspan="1">2 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">43% (1TXV)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">76% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">43% (3FCU)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">5(0.11)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;2</td>
            <td align="center" rowspan="1" colspan="1">1600 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Lys505Glu</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;-Propeller</td>
            <td align="center" rowspan="1" colspan="1">73% in model</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">6(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">1544 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Arg489Gln</td>
            <td align="center" rowspan="1" colspan="1">EGF-1</td>
            <td align="center" rowspan="1" colspan="1">76% (3FCS)</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">7(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">1297 C&gt;G</td>
            <td align="center" rowspan="1" colspan="1">Pro407Ala</td>
            <td align="center" rowspan="1" colspan="1">Hybrid</td>
            <td align="center" rowspan="1" colspan="1">27% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">17% (1TXV)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">8% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">8(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">1984 C&gt;T</td>
            <td align="center" rowspan="1" colspan="1">Arg636Cys</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;TD</td>
            <td align="center" rowspan="1" colspan="1">59% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">66% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">9(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;IIb</td>
            <td align="center" rowspan="1" colspan="1">2602 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Val837Met</td>
            <td align="center" rowspan="1" colspan="1">Calf2</td>
            <td align="center" rowspan="1" colspan="1">40% (3FCS)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">10(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">263 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Arg62Gln</td>
            <td align="center" rowspan="1" colspan="1">Hybrid</td>
            <td align="center" rowspan="1" colspan="1">32% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;-Sheet</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">63% (1TXV)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">71% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">69% (3FCU)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">11(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">1976 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Arg633His</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;TD</td>
            <td align="center" rowspan="1" colspan="1">17% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">Loop</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">53% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">12(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">GPIb &#x3B2;</td>
            <td align="center" rowspan="1" colspan="1">119 G&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Gly15Glu</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">No structure</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">2 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">13(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;2</td>
            <td align="center" rowspan="1" colspan="1">2483 C&gt;T</td>
            <td align="center" rowspan="1" colspan="1">Thr799Met</td>
            <td align="center" rowspan="1" colspan="1">Calf1</td>
            <td align="center" rowspan="1" colspan="1">32% in the model</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;-Sheet</td>
            <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">14(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">1909-11 del</td>
            <td align="center" rowspan="1" colspan="1">Lys611del</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;TD</td>
            <td align="center" rowspan="1" colspan="1">15% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;-Helix</td>
            <td align="center" rowspan="1" colspan="1">4 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">41% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">15(0.49)</td>
            <td align="center" rowspan="1" colspan="1">CD109</td>
            <td align="center" rowspan="1" colspan="1">2108 C&gt;A</td>
            <td align="center" rowspan="1" colspan="1">Tyr703Ser</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">No structure</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">4 = variable</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">16(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;3</td>
            <td align="center" rowspan="1" colspan="1">497 C&gt;T</td>
            <td align="center" rowspan="1" colspan="1">Thr140Ile</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;A</td>
            <td align="center" rowspan="1" colspan="1">51% (1JV2)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;-Helix</td>
            <td align="center" rowspan="1" colspan="1">1 = variable</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">31% (1TXV)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">55% (3FCS)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">60% (3FCU)</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">17(&lt;0.01)</td>
            <td align="center" rowspan="1" colspan="1">&#x3B1;2</td>
            <td align="center" rowspan="1" colspan="1">3389 C&gt;T</td>
            <td align="center" rowspan="1" colspan="1">Thr1087Met</td>
            <td align="center" rowspan="1" colspan="1">Calf2</td>
            <td align="center" rowspan="1" colspan="1">53 % in the model</td>
            <td align="center" rowspan="1" colspan="1">&#x3B2;-Sheet</td>
            <td align="center" rowspan="1" colspan="1">5 = intermediate</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tf1-1">
          <label>*</label>
          <p>The frequency of the rare allele in Europeans is given in parentheses.</p>
        </fn>
        <fn id="tf1-2">
          <label>&#x2020;</label>
          <p>The frequency of the rare allele in an Asian person.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Most HPAs are localized to the main PLT receptors, namely, integrin &#x3B1;IIb&#x3B2;3 that is also known as the fibrinogen receptor, the complex GPIb-IX-V that functions as the receptor for von Willebrand factor (VWF) and integrin &#x3B1;2&#x3B2;1&#x2014;the collagen receptor. Exceptional is HPA-15, which is carried by the glycosylphosphatidylinositol-linked protein CD109<xref ref-type="bibr" rid="b3">3</xref> that was found to be a part of the transforming growth factor (TGF)-&#x3B2; receptor system and functions as a negative regulator of its signaling.<xref ref-type="bibr" rid="b4">4</xref></p>
    <p>Integrins are adhesion receptors that mediate vital bidirectional signals within the cell.<xref ref-type="bibr" rid="b5">5</xref> They form heterodimers of an &#x3B1; and a &#x3B2; subunit, both Type I membrane proteins with large extracellular segments.<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b7">7</xref> There are 24 known heterodimers in mammals, composed of 18 &#x3B1; and eight &#x3B2; subunits.<xref ref-type="bibr" rid="b5">5</xref> The NH<sub>2</sub>-terminal ectodomain of the &#x3B1; and &#x3B2; subunits assembles into an ovoid &#x201C;head&#x201D; and two &#x201C;legs&#x201D; composed of several domains. The remaining segments form two tails that span the plasma membrane.<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b7">7</xref></p>
    <p>Integrin &#x3B2;3 subunit is known as PLT membrane GPIIIa that forms heterodimers with &#x3B1;IIb and &#x3B1;v integrins subunits; &#x3B1;IIb&#x3B2;3 is the most abundant PLT receptor with approximately 80,000 copies per PLT. The structure of the inactive extracellular region of &#x3B1;v&#x3B2;3 was the first one reported (PDB ID 1JV2<xref ref-type="bibr" rid="b7">7</xref>). The structure of the entire ectodomain of &#x3B1;IIb&#x3B2;3 was determined in the inactive conformation (PDB ID 3FCS<xref ref-type="bibr" rid="b8">8</xref>). The active conformation of &#x3B1;IIb&#x3B2;3 was determined only for part of the ectodomain (e.g., PDB ID 1TXV<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b9">9</xref> and 3FCU<xref ref-type="bibr" rid="b8">8</xref>). For the structural analyses, we used the crystal structures relevant to each of the HPAs.</p>
    <p>Eleven HPAs are located on the most abundant receptor on PLTs surface: integrin &#x3B1;IIb&#x3B2;3. Nine of the HPAs are mapped to the &#x3B2;3 subunit that was found to be the most polymorphic GP on the PLT membrane.<xref ref-type="bibr" rid="b10">10</xref> Some of the HPAs are frequent in the Caucasian population (HPA-3 and HPA-15) but most of them are rare and some are private polymorphisms, restricted to one family (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ipd/hpa/freqs_1.html">http://www.ebi.ac.uk/ipd/hpa/freqs_1.html</ext-link>). The antigen most commonly implicated in alloantibodies production is HPA-1a, a Leu33Pro substitution in integrin &#x3B2;3. Approximately 80% of NAIT cases are caused by anti-HPA-1a. The second frequent antigen causing NAIT is HPA-5b (10%-15% of NAIT cases), while all the rest cause NAIT very rarely.<xref ref-type="bibr" rid="b11">11</xref> Only 10% of HPA-1b&#x2013;homozygous women with an HPA-1a&#x2013;positive fetus develop anti-HPA-1a alloantibodies during pregnancy.<xref ref-type="bibr" rid="b12">12</xref> Maternal responsiveness to HPA-1a shows strong association with DRB*0101 allele encoding human histocompatibility leukocyte antigen DR52a. It was shown that short peptide containing HPA-1a (Leu33) bind to recombinant DR52a molecules, whereas the HPA-1b (Pro33) version does not.</p>
    <p>Interestingly, although most HPAs are nonsynonymous SNPs and HPA-14w is even a single-amino-acid deletion, they probably inflict a minor effect on PLT receptors function since they do not cause inherited diseases, and even their influence on thrombus formation is controversial.<xref ref-type="bibr" rid="b13">13</xref> The major complication is their involvement in immunogenic response.</p>
    <p>In this article we analyzed the structural features and evolutionary conservation of the HPAs to define the characteristics that lead to immunologic problems but not to inherited disease. We demonstrate that all HPAs studied here involve residues located on the surface of the protein far from the ligand-binding site and are not evolutionary conserved. These criteria imply that the substitutions in these positions present a minor effect on the structure and function of the protein and therefore, do not represent disease-causing mutations. Moreover, their location on the surface suggests that they could play a role in presenting epitopes.</p>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Evolutionary conservation analyses</title>
        <p>The evolutionary conservation analyses were calculated using the Bayesian method<xref ref-type="bibr" rid="b14">14</xref> implemented in the ConSurf Web server (<ext-link ext-link-type="uri" xlink:href="http://consurf.tau.ac.il">http://consurf.tau.ac.il</ext-link>)<xref ref-type="bibr" rid="b15">15</xref> or the ConSeq Web server (<ext-link ext-link-type="uri" xlink:href="http://conseq.tau.ac.il/">http://conseq.tau.ac.il/</ext-link>).<xref ref-type="bibr" rid="b16">16</xref> The conservation scores range from 1 to 9, indicating variable-to-conserved positions.</p>
        <sec>
          <title>&#x3B1;-Integrins</title>
          <p>A multiple sequence alignment (MSA) of the &#x3B2;-propeller domain in various &#x3B1;-integrins was constructed as described previously.<xref ref-type="bibr" rid="b17">17</xref> This alignment was used to calculate the conservation scores for the HPAs in the &#x3B2;-propeller domain of &#x3B1;2. An MSA of the thigh and calf domains was taken from the &#x3B1;-integrin family in the Pfam database (<ext-link ext-link-type="uri" xlink:href="http://pfam.sanger.ac.uk/">http://pfam.sanger.ac.uk/</ext-link>). This alignment corresponds to Residues 481 to 921 in &#x3B1;IIb and was used to calculate the conservation scores for the HPAs in the calf domain of &#x3B1;IIb. The last two strands of the calf2 domain constitute a very variable region among &#x3B1;-integrins and therefore were not included in the Pfam alignment. Since one of the HPAs in &#x3B1;2 is located on the C-terminus of the calf2 domain, we generated a smaller MSA via ConSeq, using &#x3B1;2 human as the query sequence to collect 50 homologs from the Swiss-Prot database<xref ref-type="bibr" rid="b18">18</xref> that were aligned using MUSCLE.<xref ref-type="bibr" rid="b19">19</xref> We note that the conservation scores for HPA-13 located in calf1 were identical when using in the Pfam and ConSurf generated alignment.</p>
        </sec>
        <sec>
          <title>&#x3B2;-Integrin</title>
          <p>Human &#x3B2;3 (Swiss-Prot entry ITB3_HUMAN) was used as query to collect homologous sequences from the Swiss-Prot database<xref ref-type="bibr" rid="b18">18</xref> using PSI-BLAST.<xref ref-type="bibr" rid="b20">20</xref> The resulted 27 sequences were aligned using CLUSTALW<xref ref-type="bibr" rid="b21">21</xref> with default parameters. This intermediate alignment was used to generate a hidden Markov model,<xref ref-type="bibr" rid="b22">22</xref> which was subsequently utilized to collect remote homologous sequences from the UniProt database<xref ref-type="bibr" rid="b23">23</xref> that were aligned using MUSCLE.<xref ref-type="bibr" rid="b19">19</xref> From the 105 hits found, redundant (above 95% sequence identity) and fragmented sequences, as well as sequence variants and mutants, were discarded along with sequences that included irregular characters or ones that were sequenced by the whole genome shotgun project therefore considered as preliminary data. The resulted alignment contained 66 &#x3B2;-integrins and was used to calculate the evolutionary conservation scores in &#x3B2;-integrins. To support the analysis, we also used an alignment generated by ConSurf using 300 homologous sequences collected from the UniProt database<xref ref-type="bibr" rid="b23">23</xref> and aligned using MUSCLE.<xref ref-type="bibr" rid="b19">19</xref> The conservation scores were very similar.</p>
        </sec>
        <sec>
          <title>Leucine-rich repeat family of proteins</title>
          <p>Human GPIb&#x3B1; (PDB ID 1SQ0, Chain B)<xref ref-type="bibr" rid="b24">24</xref> was used as query to calculate the evolutionary conservation scores via the ConSurf Web server.<xref ref-type="bibr" rid="b15">15</xref> The calculations were based on an MSA constructed from 200 homologous sequences from the Swiss-Prot database<xref ref-type="bibr" rid="b18">18</xref> collected using PSI-BLAST and aligned with MUSCLE.<xref ref-type="bibr" rid="b19">19</xref> Since the structure of human GPIb&#x3B2; (Swiss-Prot entry: GP1BB_HUMAN) is not available, we used the ConSeq Web server<xref ref-type="bibr" rid="b16">16</xref> to calculate the evolutionary conservation scores using 90 sequences collected from the Swiss-Prot database with PSI-BLAST<xref ref-type="bibr" rid="b20">20</xref> and aligned by MUSCLE.<xref ref-type="bibr" rid="b19">19</xref></p>
        </sec>
        <sec>
          <title>CD109</title>
          <p>Since the structure of human CD109 is not available (Swiss-Prot entry: CD109_HUMAN), the ConSeq Web server<xref ref-type="bibr" rid="b16">16</xref> was used to calculate the conservation scores of human CD109 based on 66 sequences collected from the Swiss-Prot database<xref ref-type="bibr" rid="b18">18</xref> using PSI-BLAST<xref ref-type="bibr" rid="b20">20</xref> and aligned by MUSCLE.<xref ref-type="bibr" rid="b19">19</xref></p>
        </sec>
      </sec>
      <sec>
        <title>Structural analyses</title>
        <p>The analyses were based on the crystal structures of &#x3B1;V&#x3B2;3 (PDB ID 1JV2),<xref ref-type="bibr" rid="b7">7</xref>&#x3B1;IIb&#x3B2;3 (PDB ID 1TXV,<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b9">9</xref> 3FCS,<xref ref-type="bibr" rid="b8">8</xref> and 3FCU),<xref ref-type="bibr" rid="b8">8</xref> and GPIb&#x3B1; (PDB ID 1SQ0).<xref ref-type="bibr" rid="b24">24</xref> The structure of &#x3B1;2 was modeled based on the crystal structure of &#x3B1;IIb&#x3B2;3 (PDB ID 3FCS<xref ref-type="bibr" rid="b8">8</xref>) using NESTs<xref ref-type="bibr" rid="b25">25</xref> with default parameters. The alignment between &#x3B1;IIb and &#x3B1;2 was derived from an MSA of 50 homologs sequences of &#x3B1;-integrins generated by ConSurf as described above. The &#x3B2;-propeller domain, lacking the I domain, was modeled separately using an alignment with &#x3B1;IIb derived from an MSA of the &#x3B2;-propeller domain of &#x3B1;-integrins constructed as described previously.<xref ref-type="bibr" rid="b17">17</xref></p>
        <p>The solvent-accessible surface area (SASA) was calculated using the SURFV program with a probe sphere of radius 1.4 &#xC5; and default parameters.<xref ref-type="bibr" rid="b26">26</xref> The percentage of the surface exposure of each residue in the monomer was calculated from the total solvent-accessible area on a Gly-X-Gly tripeptide (where X represents each of the 20 amino acids). We consider a residue to be buried if less than 5% of its surface is accessible to the solvent.<xref ref-type="bibr" rid="b27">27</xref> More importantly, we examined the location of the residue in relation to the surface of the protein.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Data are expressed as mean &#xB1; standard deviation. Kruskal-Wallis test was used to analyze the difference between groups using computer software (GraphPad PRISM5, GraphPad Software, Inc., San Diego, CA). A p value of less than 0.05 was considered as a significant difference. In case that the SASA was calculated in various structures, the mean value was used for the statistical analysis.</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>RESULTS</title>
      <sec>
        <title>HPA polymorphisms in integrin &#x3B2;3</title>
        <p>Integrin &#x3B2;3 ectodomain is composed of eight domains&#x2014;the plexins, semaphorins, and integrins (PSI); &#x3B2;A; hybrid; four epidermal growth factor (EGF) domains; and a &#x3B2;-tail domain (&#x3B2;TD). There are nine HPAs located in integrin &#x3B2;3; seven of them (HPA-4, -7, -8, -10, -11, -14, and -16) are visible in the inactive structures of both &#x3B1;v&#x3B2;3 (PDB ID 1JV2) and &#x3B1;IIb&#x3B2;3 (PDB ID 3FCS). Structural analyses of the crystal structures revealed that all HPAs are exposed to the solvent (<xref ref-type="table" rid="tbl1">Table 1</xref>) and, moreover, are located on the surface of the protein and thus do not play a role in the stabilization of the protein fold.</p>
        <p>Integrin activation is a multistep process that involves transitions between multiple conformations.<xref ref-type="bibr" rid="b6">6</xref> Correspondingly, the heterodimer is highly flexible. The &#x3B1;v&#x3B2;3 and &#x3B1;IIb&#x3B2;3 crystal structures might have captures slightly different conformations of the &#x3B2;3 that led to differences in the solvent accessibility of the HPA-related residues (<xref ref-type="table" rid="tbl1">Table 1</xref>).</p>
        <p>Some HPAs are located close to the interface with adjacent domains on the &#x3B2; subunit. For example, Arg633, the polymorphic residue of HPA-11, and Arg636, the polymorphic residue of HPA-8, both located in the &#x3B2;TD, are close to the hybrid domain. In the inactive complex &#x3B1;V&#x3B2;3, Arg633 forms a salt bridge with Asp393 from the hybrid domain and is surrounded by Leu389, Gly388, and Cys374. In the structure of &#x3B1;IIb&#x3B2;3, also in the inactive conformation, there are some conformational variations with respect to the inactive &#x3B2;3 in the &#x3B1;V&#x3B2;3 complex. In &#x3B1;IIb&#x3B2;3, Arg633 is facing away from the hybrid domain, yet might be still bound with Glu378 on the hybrid domain. Arg636 is in close proximity to Met387 and Gly388 from the hybrid domain in the &#x3B1;IIb&#x3B2;3 complex, while in the &#x3B1;V&#x3B2;3 structure, Arg636 is close to Asn376. Arg489 of HPA-6, located on the EGF-1 domain, is close to the Calf1 domain of the &#x3B1;IIb subunit (in the inactive conformation) but is not in direct contact.</p>
        <p>Five polymorphic residues involved in the formation of HPA-1, -4, -7, -10, and -16 are visible in the crystal structures of both the active (PDB IDs 3FCU<xref ref-type="bibr" rid="b8">8</xref> or 1TXV<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b9">9</xref>) and the inactive (PDB ID 3FCS)<xref ref-type="bibr" rid="b8">8</xref> conformations of integrin &#x3B1;IIb&#x3B2;3, enabling analysis in both states. Different solvent exposures of HPA-4 and -7 were detected due to structural changes in the backbone between the two conformations, as well as different rotamers (side-chain conformation; <xref ref-type="table" rid="tbl1">Table 1</xref>). Nevertheless, in both states, all HPA-related residues were found to be located on the surface of the protein, exposed to the solvent. Moreover, all of them are located far away from the ligand binding site and are not in direct contact with the &#x3B1; subunit in the structurally determined conformations (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>). Interestingly, Leu33 of the most immunogenic HPA-1a is totally exposed (<xref ref-type="table" rid="tbl1">Table 1</xref>) and found on the tip of a loop connecting two antiparallel &#x3B2;-sheets in the PSI domain. This loop is flexible and particularly long in integrins.<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b7">7</xref> The loop, and particularly Leu33, is close to the EGF domains in the inactive conformation (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>).</p>
        <fig id="fig01" position="float">
          <label>Fig. 1</label>
          <caption>
            <p>
              <bold>Structural location of the HPA-related polymorphic residues. A cartoon representation of proteins involved in HPAs. The orientation was picked to best display all HPA-related residues. Scale bar for the evolutionary conservation scores is displayed in the middle. (A) HPAs at the integrin &#x3B2;3 subunit. The ectodomain of the &#x3B1;IIb&#x3B2;3 complex is presented at the inactive conformation (PDB ID 3FCS</bold>
              <xref ref-type="bibr" rid="b8">
                <bold>
                  <sup>8</sup>
                </bold>
              </xref>
              <bold>). The &#x3B2;3 subunit is in a cartoon representation and &#x3B1;IIb is presented as a sand-colored ribbon. In the left panel, &#x3B2;3 is colored according to the different domains&#x2014;the PSI, &#x3B2;A, hybrid, EGF-1 to -2, EGF-3, EGF-4, and the &#x3B2;TD in orange, dark red, yellow, cyan, blue, magenta, and green, respectively. In the right panel, &#x3B2;3 is colored according to evolutionary conservation scores calculated based on a set of 66 homolog sequences of &#x3B2;-integrins. The HPAs polymorphic residues located in &#x3B2;3 are presented as space-filled atoms. It is clear that the HPAs are located on the surface of the protein and that they are all evolutionary variable. Also, all HPAs are facing away from the interface with the &#x3B1; subunit, suggesting that the substitutions do not disturb the heterodimeric interactions. (B) HPAs at the integrin &#x3B1;IIb subunit. The ectodomain of the &#x3B1;IIb&#x3B2;3 complex is presented at the inactive conformation (PDB ID 3FCS). &#x3B1;IIb is in a cartoon representation, colored according to the different domains&#x2014;&#x3B2;-propeller, thigh, calf1, and calf2 in purple, dark green, dark blue, and brown, respectively. &#x3B2;3 is presented as a gray-colored ribbon. Val837, associated with HPA-9, is presented as space-filled atoms. It is clear that HPA-9 is located on the surface, far from the interface with the &#x3B2; subunit. Ile843, associated with HPA-3, is located in a disordered region, illustrated with a black line, which could not be determined in the structure. (C) HPAs at the integrin &#x3B1;2. A model of &#x3B1;2, without the I-domain, was built using &#x3B1;IIb as a template. The &#x3B2;-propeller domain and the thigh and calf domains were built separately, to ensure the reliability of the alignment between &#x3B1;2 and &#x3B1;IIb. &#x3B1;2 is in a cartoon representation, colored according to the different domains&#x2014;&#x3B2;-propeller, thigh, calf1, and calf2 in purple, dark green, dark blue, and brown, respectively. The HPAs located in &#x3B1;2 are presented as space-filled atoms. &#x3B1;2 is naturally interacting with the &#x3B2;1 subunit. Taking into account that the &#x3B1;2&#x3B2;1 interactions are similar to the heterodimeric interactions within the &#x3B1;IIb&#x3B2;3 complex, the &#x3B2; subunit is illustrated accordingly. All HPA polymorphic residues in &#x3B1;2 are located on the opposite side from the interface with the &#x3B2; subunit. (D) HPAs at GPIb&#x3B1;. The GPIb&#x3B1;, in a complex with VWF (PDB ID 1SQ0), is shown in a cartoon representation. VWF domain is sand-colored, while GPIb&#x3B1; is colored according to evolutionary conservation scores. Thr145, associated with HPA-2, is presented as space-filled atoms. It is clear that HPA-2 polymorphic residue is evolutionary variable, surface exposed, and located far from the interface with the ligand VWF.</bold>
            </p>
          </caption>
          <graphic xlink:href="trf0051-0558-f1"/>
        </fig>
        <p>Evolutionary conservation analysis of &#x3B2;-integrins from different species revealed that most HPAs occupy evolutionary variable positions (<xref ref-type="table" rid="tbl1">Table 1</xref>). Moreover, some of the polymorphic residues (HPA-1b, -4b, -6b, -10b, and -11b) can be found in the corresponding positions in other &#x3B2;-integrins (<xref ref-type="table" rid="tbl2">Table 2</xref> in bold), supporting the benign effect of the amino acid substitutions on PLTs normal function. The third allele in HPA-1 (Leu33Val) is a particularly naive substitution that was also found in other &#x3B2;-integrins, showing a conservative change, in an exposed location. Interestingly, differences in reactivity of anti HPA-1a antibodies were observed, some bind also to &#x3B2;3-Val33 while others showed significantly reduced reactivity.<xref ref-type="bibr" rid="b28">28</xref></p>
        <table-wrap id="tbl2" position="float">
          <label>TABLE 2</label>
          <caption>
            <p>
              <bold>Amino acid residues occupying the HPA-related positions in &#x3B2;-integrins<xref ref-type="table-fn" rid="tf2-1">*</xref></bold>
            </p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">HPA</th>
                <th align="center" rowspan="1" colspan="1">Position</th>
                <th align="center" rowspan="1" colspan="1">Common allele</th>
                <th align="center" rowspan="1" colspan="1">Rare allele</th>
                <th align="center" rowspan="1" colspan="1">Residue variety in &#x3B2;-integrins</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">1</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>33</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Leu</td>
                <td align="center" rowspan="1" colspan="1">Pro (Val)</td>
                <td align="center" rowspan="1" colspan="1">A, D, E, G, K, <bold>L</bold>, M, N, <bold>P</bold>, Q, S, T, <bold>V</bold>, Y</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">4</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>143</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Arg</td>
                <td align="center" rowspan="1" colspan="1">Gln</td>
                <td align="center" rowspan="1" colspan="1">A, E, G, K, N, <bold>Q, R</bold>, S, T, V</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">6</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>489</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Arg</td>
                <td align="center" rowspan="1" colspan="1">Gln</td>
                <td align="center" rowspan="1" colspan="1">A, D, E, G, H, K, N, P, <bold>Q, R,</bold> S, T, V</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">7</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>407</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Pro</td>
                <td align="center" rowspan="1" colspan="1">Ala</td>
                <td align="center" rowspan="1" colspan="1">D, E, H, I, K, L, <bold>P</bold>, Q, R, S, T, V</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">8</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>636</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Arg</td>
                <td align="center" rowspan="1" colspan="1">Cys</td>
                <td align="center" rowspan="1" colspan="1">D, E, G, H, K, L, N, P, Q, <bold>R</bold>, S, T, Y</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">10</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>62</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Arg</td>
                <td align="center" rowspan="1" colspan="1">Gln</td>
                <td align="center" rowspan="1" colspan="1">D, E, F, H, I, K, L, N, <bold>Q, R</bold>, S, T, V</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>633</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Arg</td>
                <td align="center" rowspan="1" colspan="1">His</td>
                <td align="center" rowspan="1" colspan="1">A, D, E, G, <bold>H</bold>, K, L, N, Q, <bold>R</bold>, S, T, V</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">14</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>611</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Lys</td>
                <td align="center" rowspan="1" colspan="1">del</td>
                <td align="center" rowspan="1" colspan="1">D, F, H, <bold>K</bold>, L, N, Q, R, S, Y</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">16</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>140</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">Thr</td>
                <td align="center" rowspan="1" colspan="1">Ile</td>
                <td align="center" rowspan="1" colspan="1">A, D, E, G, K, L, N, Q, R, S, <bold>T</bold>, V</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tf2-1">
              <label>*</label>
              <p>The residue variety was gathered using the ConSurf server and was based on an alignment of &#x3B2; subunit integrins. For each HPA-related position, the identity of the amino acid in each of the 66 homolog sequences in the alignment was examined. A list of all possible amino acid identities for the specific position is reported. The amino acid identity occupying the positions in human &#x3B2;3 HPAs is in bold.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>The residue related to HPA-7 (Pro407) is unique among other HPAs because it shows an intermediate evolutionary conservation. Nonetheless, this position can be occupied by a variety of amino acids and is not restricted to proline in &#x3B2;-integrins from other species (<xref ref-type="table" rid="tbl2">Table 2</xref>). Pro407 is located on a loop at the hybrid domain, facing the solvent, and is not in close proximity to other domains in the structurally determined conformation of integrin &#x3B2;3. The substitution (Pro407Ala) probably has a minor effect on the structure.</p>
        <p>HPA-14, the single-deletion polymorphism, Lys611del, is located within the &#x3B2;TD, at the C-terminus of the ectodomain. The region encompassing Lys611 forms a helix in the &#x3B1;V&#x3B2;3 structure; thus such a deletion might disrupt the structure. However, this helix is partially unwound in the &#x3B1;IIb&#x3B2;3 inactive conformation (PDB ID 3FCS) raising uncertainties about its stability and contribution to the overall fold.</p>
        <p>Recently, two additional low-frequency SNPs, not yet approved as HPAs, were reported within integrin &#x3B2;3: Lys137Gln and Glu628Lys.<xref ref-type="bibr" rid="b29">29</xref> Both positions are highly evolutionary variable and located on the surface of the protein (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>), consistent with the other HPAs.</p>
      </sec>
      <sec>
        <title>HPA polymorphisms in integrin &#x3B1;IIb</title>
        <p>Integrin &#x3B1;IIb (PLT membrane GPIIb) comprises the &#x3B2;-propeller, thigh, and two calf domains. Two HPAs (HPA-3 and -9) were found in the &#x3B1;IIb integrin. Both related residues (Ile843 and Val837, respectively) are located in the calf2 domain (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>), within a highly evolutionary variable region that shows many insertions and deletions among &#x3B1;-integrins. This region is disordered in the crystal structures, suggesting that it is flexible. Val837 is visible in the inactive structure of &#x3B1;IIb&#x3B2;3.<xref ref-type="bibr" rid="b8">8</xref> It is located on a loop facing the solvent, far from the &#x3B2; subunit or other domains in &#x3B1;IIb (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>). Residues 840 to 873 are missing in the crystal structure of &#x3B1;IIb&#x3B2;3 (due to the disorder of that region); thus we could not examine Ile843.</p>
        <p>Recently, a low-frequency HPA was found in &#x3B1;IIb corresponding to Thr619Met substitution<xref ref-type="bibr" rid="b29">29</xref> at the calf1 domain. As observed for the other HPAs, this position is highly evolutionary variable (ConSurf score = 1; see Materials and Methods) and located on the surface of the protein (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>).</p>
      </sec>
      <sec>
        <title>HPA polymorphisms in integrin &#x3B1;2</title>
        <p>Integrin &#x3B1;2 (PLT membrane GPIa) forms hetrodimers with integrin &#x3B2;1 and, similarly to the integrins discussed above, is important for PLT function. Three polymorphic residues in the &#x3B1;2 integrin form antigens, HPA-5, -13, and -17, localized to the &#x3B2;-propeller, calf1, and calf2 domains, respectively. Since the only crystal structure of &#x3B1;2 is for the I-domain in the &#x3B2;-propeller (PDB ID 1AOX<xref ref-type="bibr" rid="b30">30</xref>), we modeled the rest of the structure using &#x3B1;IIb (PDB ID 3FCS)<xref ref-type="bibr" rid="b8">8</xref> as a template.</p>
        <p>The second common allele causing NAIT (HPA-5b), affecting Lys505, is located on one of the loops of the &#x3B2;-propeller domain, on the surface of the protein, far from the interface with the &#x3B2; subunit (<xref ref-type="fig" rid="fig01">Fig. 1C</xref>). Lys505 corresponds to Arg355 in &#x3B1;IIb; this position, as well as the surrounding residues on the loop, is evolutionary variable (<xref ref-type="table" rid="tbl1">Table 1</xref>). The rare HPA-13b is related to the substitution of Thr799 located within a &#x3B2;-strand in the calf1 domain, facing the solvent (<xref ref-type="fig" rid="fig01">Fig. 1C</xref>). This position, which corresponds to Asp636 in &#x3B1;IIb, shows intermediate conservation, yet is occupied by the polymorphic methionine in other &#x3B1;-integrins, suggesting tolerance to such substitution. HPA-17, affecting Thr1087, is located at the C-terminus of the calf2 domain. Thr1087 shows intermediate conservation among the closest 50 sequences homologous to the human &#x3B1;2 (<xref ref-type="table" rid="tbl1">Table 1</xref>), yet is located in a region that is highly variable between &#x3B1;-integrins. Integrin &#x3B1;2 forms a complex with &#x3B2;1. Taking into account that the interactions between the &#x3B1; and &#x3B2; subunits resemble those of &#x3B1;IIb&#x3B2;3 and &#x3B1;V&#x3B2;3, all three HPAs on &#x3B1;2 are located on the opposite side from the interface with the &#x3B2; subunit.</p>
      </sec>
      <sec>
        <title>HPA polymorphisms in the GPIb-V-IX complex</title>
        <p>The GPIb-V-IX complex, another PLT receptor, is composed of four Type I membrane spanning proteins that belong to the leucine-rich repeat (LRR) family of proteins: GPIb&#x3B1;, GPIb&#x3B2;, GPIX, and GPV. HPA-2 and HPA-12 are localized to the two first GPs, respectively. Crystal structures are available only for the LRR domain of GPIb&#x3B1; (e.g., PDB ID 1SQ0). HPA-2, affecting Thr145, is located in this region, on the surface of the protein, facing the solvent. It is located far from the interface with its ligand, the VWF (<xref ref-type="fig" rid="fig02">Fig. 2D</xref>).</p>
        <fig id="fig02" position="float">
          <label>Fig. 2</label>
          <caption>
            <p>Characterization of HPAs, disease-causing missense mutations, and nonimmunogenic SNPs. Conservation score (n = 17) and residue's SASA (n = 14) of HPA-related polymorphic residues (&#x25A1;), missense mutations causing disease (n = 13,<graphic xlink:href="trf0051-0558-fu1"/>), and nonimmunogenic polymorphism (n = 8, <graphic xlink:href="trf0051-0558-fu2"/>) presented as mean &#xB1; SD. Significant differences marked as * p &lt; 0.05 and ***p &lt; 0.001.</p>
          </caption>
          <graphic xlink:href="trf0051-0558-f2"/>
        </fig>
        <p>The GPIb-V-IX complex is known to regulate thrombin function by distinct interactions.<xref ref-type="bibr" rid="b31">31</xref> There are two crystal structures of thrombin bound to GPIb&#x3B1; (PDB IDs 1P8V<xref ref-type="bibr" rid="b32">32</xref> and 1OOK<xref ref-type="bibr" rid="b31">31</xref>). The two structures present different interpretations to how the two proteins interact.<xref ref-type="bibr" rid="b33">33</xref> In one of these structures (PDB ID 1P8V),<xref ref-type="bibr" rid="b32">32</xref> Thr145 is located at the interface with one of the thrombin molecules. Recently a model of GPIb&#x3B2; ectodomain was constructed, based on decorin crystal structure (PDB ID 1XKU<xref ref-type="bibr" rid="b34">34</xref>), but is not yet available for analysis.<xref ref-type="bibr" rid="b35">35</xref></p>
      </sec>
      <sec>
        <title>HPA polymorphisms in CD109</title>
        <p>CD109 antigen, also known as PLT-specific Gov antigen, is a TGF-&#x3B2;1 binding protein for which no structure is available. The closest homolog with known structure has 26% sequence identity, which is not enough for accurate structural modeling. Tyr703 (Residue 682 in the mature protein), associated with HPA15, is evolutionary variable.</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>DISCUSSION</title>
      <sec>
        <title>Polymorphisms versus disease-causing mutations</title>
        <p>Most HPAs are localized to integrin &#x3B1;IIb&#x3B2;3, specifically to the &#x3B2;3 subunit.<xref ref-type="bibr" rid="b10">10</xref> Several missense mutations in this integrin were reported to cause severe bleeding disorder named Glanzmann thrombasthenia (GT) (<ext-link ext-link-type="uri" xlink:href="http://sinaicentral.mssm.edu/intranet/research/glanzmann/menu">http://sinaicentral.mssm.edu/intranet/research/glanzmann/menu</ext-link>). Single-nucleotide sequence alterations responsible for both HPAs and GT result in nonsynonymous amino acid substitutions. The interesting question is why some amino acid substitutions cause disease while others are naive polymorphisms.<xref ref-type="bibr" rid="b36">36</xref>,<xref ref-type="bibr" rid="b37">37</xref> Moreover, some SNPs are immunogenic, while others were not reported to cause an immune response. Our working hypothesis is that mutations in residues that are evolutionary conserved and are deeply buried within the fold of the protein or located near the active site, near the ligand binding site or at the interfaces with other domains, are most likely to damage the structure and function of the protein. On the other hand, substitutions in residues that are located on the surface of the protein and are evolutionary variable will be more tolerable. Having this in mind, we examined the HPAs in terms of evolutionary conservation and structural characteristics. In comparison we analyzed mutations causing GT or Bernard-Soulier syndrome (BSS) previously reported by us (<xref ref-type="table" rid="tbl3">Table 3</xref>) and validated (by frequency in any population) SNPs found in NCBI SNP database that were not reported to cause an immune response (<xref ref-type="table" rid="tbl4">Table 4</xref>).</p>
        <table-wrap id="tbl4" position="float">
          <label>TABLE 4</label>
          <caption>
            <p>
              <bold>Disease-causing mutations</bold>
            </p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Gene</th>
                <th align="center" rowspan="1" colspan="1">Missense mutation</th>
                <th align="center" rowspan="1" colspan="1">Amino acid</th>
                <th align="center" rowspan="1" colspan="1">Domain</th>
                <th align="center" rowspan="1" colspan="1">Residue's SASA</th>
                <th align="center" rowspan="1" colspan="1">Conservation score</th>
                <th align="center" rowspan="1" colspan="1">Disease</th>
                <th align="center" rowspan="1" colspan="1">Reference</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">1157 T&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Cys13Gly</td>
                <td align="center" rowspan="1" colspan="1">PSI</td>
                <td align="center" rowspan="1" colspan="1">0.3% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0.64% (3FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">356 G&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Arg93Glu</td>
                <td align="center" rowspan="1" colspan="1">Hybrid</td>
                <td align="center" rowspan="1" colspan="1">1.4% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.4% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">14.5% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">428 T&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Leu117Trp</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;A</td>
                <td align="center" rowspan="1" colspan="1">0% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">652 C&gt;T</td>
                <td align="center" rowspan="1" colspan="1">His192Tyr</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;A</td>
                <td align="center" rowspan="1" colspan="1">4.3% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.9% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.7% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">1261 G&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Val395Met</td>
                <td align="center" rowspan="1" colspan="1">Hybrid</td>
                <td align="center" rowspan="1" colspan="1">3.7% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">8 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.4% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4.3% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">1723 T&gt;C</td>
                <td align="center" rowspan="1" colspan="1">Cys549Arg</td>
                <td align="center" rowspan="1" colspan="1">EGF-3</td>
                <td align="center" rowspan="1" colspan="1">13.97% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Mor-Cohen et al.<xref ref-type="bibr" rid="b51">51</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">23.29% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">97 A&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Asn2Asp</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-propeller</td>
                <td align="center" rowspan="1" colspan="1">0.55% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Mansour et al.<xref ref-type="bibr" rid="b52">52</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4.93% (3FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">416 C&gt;T</td>
                <td align="center" rowspan="1" colspan="1">Ala108Val</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-propeller</td>
                <td align="center" rowspan="1" colspan="1">0% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">8 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">607 T&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Phe171Cys</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-propeller</td>
                <td align="center" rowspan="1" colspan="1">24.2% (3FCS)<xref ref-type="table-fn" rid="tf4-1">*</xref></td>
                <td align="center" rowspan="1" colspan="1">8 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Rosenberg et al.<xref ref-type="bibr" rid="b17">17</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">23.5% (FCU)<xref ref-type="table-fn" rid="tf4-1">*</xref></td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1% in the complex</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">886 G&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Gly265Arg</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-propeller</td>
                <td align="center" rowspan="1" colspan="1">0.1% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">1139 G&gt;T</td>
                <td align="center" rowspan="1" colspan="1">Gly349Val</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-propeller</td>
                <td align="center" rowspan="1" colspan="1">8.5% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">8 = conserved</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Peretz et al.<xref ref-type="bibr" rid="b38">38</xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">7.8% (FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">2438 C&gt;A</td>
                <td align="center" rowspan="1" colspan="1">His782Asn</td>
                <td align="center" rowspan="1" colspan="1">Calf-2</td>
                <td align="center" rowspan="1" colspan="1">5.02% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
                <td align="center" rowspan="1" colspan="1">GT</td>
                <td align="center" rowspan="1" colspan="1">Losonczy et al.<xref ref-type="bibr" rid="b53">53</xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">GPIb&#x3B1;</td>
                <td align="center" rowspan="1" colspan="1">709 T&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Trp207Gly</td>
                <td align="center" rowspan="1" colspan="1">S-S loop</td>
                <td align="center" rowspan="1" colspan="1">0% (1SQ0)</td>
                <td align="center" rowspan="1" colspan="1">5 = intermediate</td>
                <td align="center" rowspan="1" colspan="1">BSS</td>
                <td align="center" rowspan="1" colspan="1">Rosenberg et al.<xref ref-type="bibr" rid="b39">39</xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tf4-1">
              <label>*</label>
              <p>F171 is on the interface with &#x3B2;3. In the structure of the heterodimer, F171 is only 1% exposed to the solvent.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="tbl3" position="float">
          <label>TABLE 3</label>
          <caption>
            <p>
              <bold>Analyses of nonsynonym polymorphisms in integrin &#x3B1;IIb&#x3B2;3 that have not been reported as immunogenic antigens</bold>
            </p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Gene</th>
                <th align="center" rowspan="1" colspan="1">SNP</th>
                <th align="center" rowspan="1" colspan="1">Amino acid</th>
                <th align="center" rowspan="1" colspan="1">Domain</th>
                <th align="center" rowspan="1" colspan="1">Residue's SASA</th>
                <th align="center" rowspan="1" colspan="1">Conservation score</th>
                <th align="center" rowspan="1" colspan="1">Database</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">217 T&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Leu40Arg</td>
                <td align="center" rowspan="1" colspan="1">PSI</td>
                <td align="center" rowspan="1" colspan="1">28.8% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">4 = variable</td>
                <td align="center" rowspan="1" colspan="1">rs36080296</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">20.7% (3FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">366 C&gt;T</td>
                <td align="center" rowspan="1" colspan="1">Leu90Phe</td>
                <td align="center" rowspan="1" colspan="1">Hybrid</td>
                <td align="center" rowspan="1" colspan="1">0.56% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
                <td align="center" rowspan="1" colspan="1">rs72547409</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0.61% (3FCU</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.27% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">1377 G&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Val427Ile</td>
                <td align="center" rowspan="1" colspan="1">Hybrid</td>
                <td align="center" rowspan="1" colspan="1">0% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">6 = intermediate</td>
                <td align="center" rowspan="1" colspan="1">rs5921</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (3FCU)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B2;3</td>
                <td align="center" rowspan="1" colspan="1">1980 G&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Glu628Lys</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;TD</td>
                <td align="center" rowspan="1" colspan="1">66.5% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">1 = variable</td>
                <td align="center" rowspan="1" colspan="1">rs70940817</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">45.6% (1JV2)</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">440 C&gt;G</td>
                <td align="center" rowspan="1" colspan="1">Leu116Val</td>
                <td align="center" rowspan="1" colspan="1">&#x3B2;-Propeller</td>
                <td align="center" rowspan="1" colspan="1">34.9% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">1 = variable</td>
                <td align="center" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">35.8% (3FCU</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">1977 G&gt;T</td>
                <td align="center" rowspan="1" colspan="1">Val618Leu</td>
                <td align="center" rowspan="1" colspan="1">Calf1</td>
                <td align="center" rowspan="1" colspan="1">16.8% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">1 = variable</td>
                <td align="center" rowspan="1" colspan="1">rs7207402</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">2300 C&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Ser725Arg</td>
                <td align="center" rowspan="1" colspan="1">Calf1</td>
                <td align="center" rowspan="1" colspan="1">11.6% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">9 = conserved</td>
                <td align="center" rowspan="1" colspan="1">rs74563314</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B1;IIb</td>
                <td align="center" rowspan="1" colspan="1">2934 T&gt;A</td>
                <td align="center" rowspan="1" colspan="1">Tyr937Asn</td>
                <td align="center" rowspan="1" colspan="1">Calf2</td>
                <td align="center" rowspan="1" colspan="1">23.7% (3FCS)</td>
                <td align="center" rowspan="1" colspan="1">4 = variable</td>
                <td align="center" rowspan="1" colspan="1">rs2934</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Our structural analysis revealed that the SNPs responsible for the HPAs affected nonconserved positions located on the surface of the protein, far away from the ligand binding site and not in direct contact with other subunits. In contrast, disease-causing mutations within integrins often disturb highly conserved and buried positions in the proteins' cores<xref ref-type="bibr" rid="b38">38</xref> (<xref ref-type="table" rid="tbl4">Table 4</xref>, <xref ref-type="fig" rid="fig02">Fig. 2</xref>), which imply that they are essential for maintaining the basic structure common to all integrins. Similarly, a missense mutation leading to a rare bleeding disorder, BSS, was mapped to an evolutionary conserved and hydrophobic residue at the core of the LRR region in the GPIb-IX-V complex.<xref ref-type="bibr" rid="b39">39</xref> In contrast, Thr145 responsible for HPA-2, located at the same repeat region (<xref ref-type="fig" rid="fig01">Fig. 1D</xref>), is exposed to the solvent and is evolutionary variable. Consequently, we raised the question whether immunogenicity of HPAs, as opposed to SNPs not reported to cause an immune response, is the consequence of the presence of evolutionary variable and exposed residues in HPAs. Analyses of integrin &#x3B1;IIb&#x3B2;3 polymorphisms that were not published as immunogenic showed that some polymorphic residues are evolutionary variable and exposed similarly to HPAs, while others are buried. Only one polymorphism was shown to be evolutionary conserved, but not buried as found for missense mutations (<xref ref-type="table" rid="tbl4">Table 4</xref>). Statistical analysis showed that HPAs differed significantly from causing disease missense mutations in both variables: evolutionary conservation and SASA (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). In contrast, HPAs differed from nonimmunogenic polymorphisms in SASA but not in their conservation score, suggesting that the immunogenicity is dependent mostly on the structural location of the residue. Interestingly, it was found that nonimmunogenic polymorphisms differed significantly from missense mutations in the evolutionary score but not in the SASA (<xref ref-type="fig" rid="fig02">Fig. 2</xref>).</p>
        <p>Taken together, we can conclude that although disease-causing mutations and SNPs responsible for HPAs can be localized to the same domain, they differ in their evolutionary conservation and solvent exposure. Interestingly, although most HPAs result in substituting chemically dissimilar residues, they have no dramatic effects on the apparent function of the proteins. The observations that these positions are evolutionary variable and surface exposed explain their tolerance to substitutions for residues of various properties. Actually, in most cases, the amino acid of the polymorphic residue was found in equivalent positions within homologous proteins (<xref ref-type="table" rid="tbl2">Table 2</xref>). It is interesting to note that many of the HPA-related positions are occupied by positively charged residues. Substitutions would therefore lead to alteration of the surface electrostatic potential. This might be related to the formation of unique interfaces that lead to antigenicity and to the production of antibodies. The antigenicity of the polymorphisms seems to be dependent on the amino acid residue, as shown for HPA-1. The immunization against HPA-1a (Leu33) is known to be the most common cause of NAIT (80%) while the HPA-1b allele (Pro33) is responsible for only approximately 4% of NAIT cases. This discrepancy in the frequencies is probably due to a different antigenicity of the alleles, as shown by the observation that peptides containing the Leu33 polymorphism bind to recombinant DR52a molecules, whereas the Pro33 version does not.<xref ref-type="bibr" rid="b12">12</xref> Similarly, HPA-5b allele is immunogenic and the HPA-5a is not (10% in NAIT compared to 0%). Although the likelihood of antigen incompatibility between mother and fetus is very high in HPA-3 and HPA-15 systems, due to their high heterozygosity rate, they are less likely to cause NAIT compared to HPA-1 and HPA-5 systems. Interestingly, HPA-1 and -5 are associated with very low evolutionary conservation (1 = variable) and very high residue SASA (<xref ref-type="table" rid="tbl1">Table 1</xref>).</p>
      </sec>
      <sec>
        <title>Some HPAs are nonlinear epitopes</title>
        <p>Leu33 involved in HPA-1 is located in a loop of the PSI domain of integrin &#x3B2;3, totally exposed to the solvent in both the active and the inactive conformations of &#x3B1;IIb&#x3B2;3 (<xref ref-type="table" rid="tbl1">Table 1</xref>). HPA-1 was shown to be a part of a nonlinear epitope<xref ref-type="bibr" rid="b40">40</xref> sensitive to disulfide bond reduction or cysteine substitution in the PSI domain.<xref ref-type="bibr" rid="b41">41</xref> This suggests that the epitope is dependent on the intact tertiary structure of its domain. Moreover, substitutions such as Arg93Gln or Pro407Ala (of HPA-7), both localized to the hybrid domain, were shown to be critical for binding of anti-HPA-1a antibodies.<xref ref-type="bibr" rid="b42">42</xref> This indicates that the HPA-1a epitope is dependent on residues in the neighboring hybrid domain. The sensitivity of the HPA-1a epitope to polymorphisms located in neighboring region can explain its heterogeneous nature as demonstrated by the third allele Val33, which reacts with some anti-HPA-1a but not with others.<xref ref-type="bibr" rid="b12">12</xref> In addition to HPA-1, epitopes of other HPAs were also shown to be nonlinear<xref ref-type="bibr" rid="b43">43</xref> and affect posttranslation process: For instance, Arg636Cys (constructed HPA-8) alters the N-linked glycosylation pattern<xref ref-type="bibr" rid="b44">44</xref> and deletion of Lys611 (HPA-14b) modifies the disulfide bond pattern, both mapped to the &#x3B2;TD of integrin &#x3B2;3. Similarly, HPA-3 determinant, caused by Ile843Ser substitution in integrin &#x3B1;IIb, is dependent upon O-linked carbohydrate.<xref ref-type="bibr" rid="b45">45</xref> The dependency of the immune response on the glycosylation state can explain the heterogeneous nature of this epitope. It has been shown that some anti-HPA-3a require sialic acid or O-linked oligosaccharide residues for reactivity, whereas others do not.<xref ref-type="bibr" rid="b45">45</xref></p>
      </sec>
      <sec>
        <title>Association between HPA epitopes and activation states of integrins</title>
        <p>Integrins such as &#x3B1;IIb&#x3B2;3 were shown to be in a bent inactive conformation on the resting PLT. After physiologic activation, the integrins shift to the extended active conformation leading to exposure of multiple new epitopes named LIBS (ligand-induced binding site).<xref ref-type="bibr" rid="b6">6</xref> The activation mechanism of the integrins involves multiconformations of both subunits;<xref ref-type="bibr" rid="b6">6</xref> few were recapitulated in the available crystal structures.<xref ref-type="bibr" rid="b6">6</xref>&#x2013;<xref ref-type="bibr" rid="b8">8</xref> We found some differences in the SASA of HPA-related residues in the various conformations of the &#x3B2;3 subunit due to structural changes in the backbone as well as different rotamers (side-chain conformation; <xref ref-type="table" rid="tbl1">Table 1</xref>). It is possible that structural changes and rearrangements of interdomain orientation accompanying the activation process lead to alterations in the presentation of the HPAs' epitopes. Correspondingly, some HPA-related residues are mapped to the same regions harboring the LIBS epitopes that become exposed on activation. For example, few LIBS epitopes, as well as HPAs-1, -6, -8, -11, and -14 of &#x3B2;3 integrin, are located in the PSI, &#x3B2;TD, and EGF domains.<xref ref-type="bibr" rid="b8">8</xref> Similarly, the epitopes for HPA-3 and -9 at the &#x3B1;IIb integrin, as well as the epitope to the LIBS antibody PMI-1,<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b45">45</xref> are mapped to the same region&#x2014;an unstructured loop in the calf2 domain of &#x3B1;IIb. This loop is cleaved during biosynthesis, thus enabling breathing movements that can shift the equilibrium toward integrin extension.<xref ref-type="bibr" rid="b8">8</xref> The antigenic determinant of HPA-3 is similar to that of the LIBS antibody PMI-1, suggesting that the activation state might also affect exposure of the HPA-3 epitope.<xref ref-type="bibr" rid="b45">45</xref></p>
        <p>The rearrangements of interdomain orientation during activation impinge on the presentation of the HPA epitopes. Then again, some HPA polymorphisms can have an effect on the dynamic of the conformational changes involved in the activation process. For example, Arg633 in &#x3B2;3, the residue substituted in HPA-11, was shown to be important for constraining &#x3B1;IIb&#x3B2;3 in a low-affinity state. Correspondingly, the polymorphism Arg633His can enhance the separation of domains. Interfering with interdomain interactions can increase protein flexibility and initiate the extension of the integrin.<xref ref-type="bibr" rid="b46">46</xref> Another example is HPA-1b where a Pro33 in &#x3B2;3 subunit has been reported to cause hypercoagulability effects<xref ref-type="bibr" rid="b47">47</xref> due to increased aggregability,<xref ref-type="bibr" rid="b48">48</xref> different sensitivity to agonists,<xref ref-type="bibr" rid="b49">49</xref> or enhancement of outside-in signaling.<xref ref-type="bibr" rid="b50">50</xref> It is possible that the polymorphism might partially mimic the activated conformation. Our analyses show that both Arg633 and Leu33 in &#x3B2;3 are located close to the interface with other domains, implying that the substitutions might affect interdomain rearrangements. Taken together, these data suggest that although the residues that form the HPAs are probably not involved in stabilizing the three-dimensional fold, their surface location might shape the rigidity of the protein, and influence the interdomain orientation, thus making the protein more prone to activation.</p>
        <p>In conclusion, our analyses provide a unique perspective to the molecular basis of amino acid substitutions leading to the formation of epitopes for auto-/alloantibodies. The HPAs involve SNPs at evolutionary variable positions located on the protein surface. These polymorphisms do not cause diseases but lead to immunologic disorders. Interestingly, some HPAs might also affect the activation process of the protein. The integrins form hetrodimers, whereas each subunit comprises multiple domains. This allows a regulation mechanism that involves multiple conformations of the protein on the cell surface. Our analyses show that some HPAs involve substitutions at positions located at the interface between domains and thereby might affect interdomain rearrangement and the activation dynamics.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr Ariella Zivelin and Dr Rima Dardik for their critical review of the article.</p>
    </ack>
    <sec>
      <title>CONFLICT OF INTEREST</title>
      <p>The authors have no disclaimers to make or conflicts to disclose relevant to this manuscript.</p>
    </sec>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metcalfe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Ouwehand</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kekomaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>De Haas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kiefel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Santoso</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Nomenclature of human platelet antigens</article-title>
          <source>Vox Sang</source>
          <year>2003</year>
          <volume>85</volume>
          <fpage>240</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">14516468</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santoso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kiefel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>IG</given-names>
            </name>
            <name>
              <surname>Sachs</surname>
              <given-names>UJ</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>1205</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">11830467</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuh</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Harmer</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Prosper</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Metcalfe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Horsfall</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ouwehand</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>1692</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11861285</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finnson</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Marcoux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lepage</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bizet</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Philip</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes</article-title>
          <source>FASEB J</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>1525</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">16754747</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hynes</surname>
              <given-names>RO</given-names>
            </name>
          </person-group>
          <article-title>Integrins: bidirectional, allosteric signaling machines</article-title>
          <source>Cell</source>
          <year>2002</year>
          <volume>110</volume>
          <fpage>673</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">12297042</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>432</volume>
          <fpage>59</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">15378069</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiong</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Stehle</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Diefenbach</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dunker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Joachimiak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Arnaout</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of the extracellular segment of integrin alpha Vbeta3</article-title>
          <source>Science</source>
          <year>2001</year>
          <volume>294</volume>
          <fpage>339</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">11546839</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces</article-title>
          <source>Mol Cell</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>849</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">19111664</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Springer</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3</article-title>
          <source>J Cell Biol</source>
          <year>2008</year>
          <volume>182</volume>
          <fpage>791</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="pmid">18710925</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Valentin</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Human platelet alloantigens: recent findings, new perspectives</article-title>
          <source>Thromb Haemost</source>
          <year>1995</year>
          <volume>74</volume>
          <fpage>234</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8578464</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davoren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia</article-title>
          <source>Transfusion</source>
          <year>2004</year>
          <volume>44</volume>
          <fpage>1220</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">15265127</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anani Sarab</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Urbaniak</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells</article-title>
          <source>Blood</source>
          <year>2009</year>
          <volume>114</volume>
          <fpage>1954</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">19494351</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Castelnuovo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Gaetano</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Benedetta Donati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Iacoviello</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice</article-title>
          <source>Am J Pharmacogenomics</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>93</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15813672</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayrose</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pupko</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Site-specific evolutionary rate inference: taking phylogenetic uncertainty into account</article-title>
          <source>J Mol Evol</source>
          <year>2005</year>
          <volume>60</volume>
          <fpage>345</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">15871045</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mayrose</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Glaser</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Martz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pupko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ben-Tal</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures</article-title>
          <source>Nucleic Acids Res</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>W299</fpage>
          <lpage>302</lpage>
          <comment>Web Server issue</comment>
          <pub-id pub-id-type="pmid">15980475</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berezin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Glaser</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Paz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pupko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fariselli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Casadio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ben-Tal</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>ConSeq: the identification of functionally and structurally important residues in protein sequences</article-title>
          <source>Bioinformatics</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>1322</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">14871869</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Landau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luboshitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rechavi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation</article-title>
          <source>J Thromb Haemost</source>
          <year>2004</year>
          <volume>2</volume>
          <fpage>1167</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">15219201</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bairoch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Apweiler</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999</article-title>
          <source>Nucleic Acids Res</source>
          <year>1999</year>
          <volume>27</volume>
          <fpage>49</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">9847139</pub-id>
        </element-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edgar</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>
          <source>Nucleic Acids Res</source>
          <year>2004</year>
          <volume>32</volume>
          <fpage>1792</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">15034147</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Altschul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Madden</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schaffer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lipman</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>
          <source>Nucleic Acids Res</source>
          <year>1997</year>
          <volume>25</volume>
          <fpage>3389</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="pmid">9254694</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Clustal</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</article-title>
          <source>Nucleic Acids Res</source>
          <year>1994</year>
          <volume>22</volume>
          <fpage>4673</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">7984417</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eddy</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Hidden Markov models</article-title>
          <source>Curr Opin Struct Biol</source>
          <year>1996</year>
          <volume>6</volume>
          <fpage>361</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">8804822</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bairoch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Apweiler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Boeckmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gasteiger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Magrane</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Natale</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>O'Donovan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Redaschi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>The universal protein resource (UniProt)</article-title>
          <source>Nucleic Acids Res</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>D154</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15608167</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dumas</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McDonagh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Somers</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Mosyak</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>23327</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">15039442</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petrey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gimpelev</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mitros</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Goldsmith-Fischman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kernytsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schlessinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>IY</given-names>
            </name>
            <name>
              <surname>Alexov</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Honig</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling</article-title>
          <source>Proteins</source>
          <year>2003</year>
          <volume>53</volume>
          <fpage>430</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">14579332</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bajaj</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chakrabarti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Varadarajan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Mutagenesis-based definitions and probes of residue burial in proteins</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>16221</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">16251276</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sridharan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nicholls</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Honig</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A new vertex algorithm to calculate solvent accessible surface area</article-title>
          <source>Biophys J</source>
          <year>1992</year>
          <volume>61</volume>
          <fpage>A174</fpage>
        </element-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santoso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Andrei-Selmer</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Socher</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kretzschmar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Ouwehand</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1</article-title>
          <source>Transfusion</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>790</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16686847</pub-id>
        </element-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peterson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gitter</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Kanack</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bougie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia</article-title>
          <source>Transfusion</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>324</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">19821948</pub-id>
        </element-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emsley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Farndale</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Liddington</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Structural basis of collagen recognition by integrin alpha2beta1</article-title>
          <source>Cell</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>47</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">10778855</pub-id>
        </element-citation>
      </ref>
      <ref id="b31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Celikel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McClintock</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Mendolicchio</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Varughese</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Ruggeri</surname>
              <given-names>ZM</given-names>
            </name>
          </person-group>
          <article-title>Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>301</volume>
          <fpage>218</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">12855810</pub-id>
        </element-citation>
      </ref>
      <ref id="b32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dumas</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seehra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Somers</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Mosyak</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>301</volume>
          <fpage>222</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">12855811</pub-id>
        </element-citation>
      </ref>
      <ref id="b33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadler</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Structural biology. A menage a trois in two configurations</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>301</volume>
          <fpage>177</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12855796</pub-id>
        </element-citation>
      </ref>
      <ref id="b34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>McEwan</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Dodd</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Bishop</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Bella</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>15633</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15501918</pub-id>
        </element-citation>
      </ref>
      <ref id="b35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mo</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>NX</given-names>
            </name>
            <name>
              <surname>McEwan</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Emsley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Binding of platelet glycoprotein Ibbeta through the convex surface of leucine-rich repeats domain of glycoprotein IX</article-title>
          <source>J Thromb Haemost</source>
          <year>2009</year>
          <volume>7</volume>
          <fpage>1533</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">19566547</pub-id>
        </element-citation>
      </ref>
      <ref id="b36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bromberg</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rost</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>SNAP: predict effect of non-synonymous polymorphisms on function</article-title>
          <source>Nucleic Acids Res</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>3823</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">17526529</pub-id>
        </element-citation>
      </ref>
      <ref id="b37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yue</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Melamud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Moult</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>SNPs3D: candidate gene and SNP selection for association studies</article-title>
          <source>BMC Bioinformatics</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>166</fpage>
          <pub-id pub-id-type="pmid">16551372</pub-id>
        </element-citation>
      </ref>
      <ref id="b38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peretz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Landau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Usher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Mor-Cohen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chandy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3)</article-title>
          <source>Hum Mutat</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>359</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">16463284</pub-id>
        </element-citation>
      </ref>
      <ref id="b39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lalezari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Landau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shenkman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Izraeli</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome</article-title>
          <source>J Thromb Haemost</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>378</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">17083647</pub-id>
        </element-citation>
      </ref>
      <ref id="b40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flug</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Espinola</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>LX</given-names>
            </name>
            <name>
              <surname>SinQuee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>DaRosso</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karpatkin</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope</article-title>
          <source>Blood</source>
          <year>1991</year>
          <volume>77</volume>
          <fpage>1964</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">1708295</pub-id>
        </element-citation>
      </ref>
      <ref id="b41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valentin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Visentin</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response</article-title>
          <source>Blood</source>
          <year>1995</year>
          <volume>85</volume>
          <fpage>3028</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">7756638</pub-id>
        </element-citation>
      </ref>
      <ref id="b42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watkins</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Schaffner-Reckinger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Howkins</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Brons</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Metcalfe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kieffer</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ouwehand</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>1833</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11861302</pub-id>
        </element-citation>
      </ref>
      <ref id="b43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stafford</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garner</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Huiskes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kekomaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Santoso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsuno</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Ouwehand</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies</article-title>
          <source>J Thromb Haemost</source>
          <year>2008</year>
          <volume>6</volume>
          <fpage>376</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">18031296</pub-id>
        </element-citation>
      </ref>
      <ref id="b44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santoso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kalb</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Walka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kiefel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mueller-Eckhardt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa</article-title>
          <source>J Biol Chem</source>
          <year>1994</year>
          <volume>269</volume>
          <fpage>8439</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">8132570</pub-id>
        </element-citation>
      </ref>
      <ref id="b45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Djaffar</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Vilette</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pidard</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wautier</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rosa</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Human platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates</article-title>
          <source>Thromb Haemost</source>
          <year>1993</year>
          <volume>69</volume>
          <fpage>485</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">7686694</pub-id>
        </element-citation>
      </ref>
      <ref id="b46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kamata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Iwasaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yura</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Key interactions in integrin ectodomain responsible for global conformational change detected by elastic network normal-mode analysis</article-title>
          <source>Biophys J</source>
          <year>2008</year>
          <volume>95</volume>
          <fpage>2895</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="pmid">18515366</pub-id>
        </element-citation>
      </ref>
      <ref id="b47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Bray</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Tayback</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schulman</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Kickler</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Gerstenblith</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Goldschmidt-Clermont</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis</article-title>
          <source>N Engl J Med</source>
          <year>1996</year>
          <volume>334</volume>
          <fpage>1090</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">8598867</pub-id>
        </element-citation>
      </ref>
      <ref id="b48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lindpaintner</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Lipinska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Silbershatz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tofler</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>1142</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10195947</pub-id>
        </element-citation>
      </ref>
      <ref id="b49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michelson</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Furman</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Goldschmidt-Clermont</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mascelli</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hendrix</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hamlington</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Barnard</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kickler</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Christie</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Kundu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bray</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>1013</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">10704169</pub-id>
        </element-citation>
      </ref>
      <ref id="b50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vijayan</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Bray</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: enhanced outside-in signaling through the Pro33 variant of integrin beta3</article-title>
          <source>Exp Biol Med (Maywood)</source>
          <year>2006</year>
          <volume>231</volume>
          <fpage>505</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">16636298</pub-id>
        </element-citation>
      </ref>
      <ref id="b51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mor-Cohen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Peretz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Landau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Awidi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3</article-title>
          <source>Thromb Haemost</source>
          <year>2007</year>
          <volume>98</volume>
          <fpage>1257</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">18064323</pub-id>
        </element-citation>
      </ref>
      <ref id="b52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansour</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hauschner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Koren</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation of a highly conserved residue Asn2Asp of integrin alpha-IIb causes Glanzmann thrombasthenia</article-title>
          <source>J Thromb Haemost</source>
          <year>2009</year>
          <volume>7</volume>
          <issue>Suppl 2</issue>
          <fpage>165</fpage>
          <comment>PP-TH-084 Abstract</comment>
          <pub-id pub-id-type="pmid">19630792</pub-id>
        </element-citation>
      </ref>
      <ref id="b53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Losonczy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Boda</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Vereb</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kappelmayer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hauschner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bereczky</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Muszbek</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia</article-title>
          <source>Haematologica</source>
          <year>2007</year>
          <volume>92</volume>
          <fpage>698</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="pmid">17488698</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <glossary>
      <def-list>
        <title>ABBREVIATIONS:</title>
        <def-item>
          <term>&#x3B2;TD</term>
          <def>
            <p>&#x3B2;-tail domain</p>
          </def>
        </def-item>
        <def-item>
          <term>BSS</term>
          <def>
            <p>Bernard-Soulier syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>EGF</term>
          <def>
            <p>epidermal growth factor</p>
          </def>
        </def-item>
        <def-item>
          <term>GP(s)</term>
          <def>
            <p>glycoprotein(s)</p>
          </def>
        </def-item>
        <def-item>
          <term>GT</term>
          <def>
            <p>Glanzmann thrombasthenia</p>
          </def>
        </def-item>
        <def-item>
          <term>HPA(s)</term>
          <def>
            <p>human platelet antigen(s)</p>
          </def>
        </def-item>
        <def-item>
          <term>LIBS</term>
          <def>
            <p>ligand-induced binding site</p>
          </def>
        </def-item>
        <def-item>
          <term>LRR</term>
          <def>
            <p>leucine-rich repeat</p>
          </def>
        </def-item>
        <def-item>
          <term>MSA</term>
          <def>
            <p>multiple sequence alignment</p>
          </def>
        </def-item>
        <def-item>
          <term>NAIT</term>
          <def>
            <p>neonatal alloimmune thrombocytopenia</p>
          </def>
        </def-item>
        <def-item>
          <term>PLT</term>
          <def>
            <p>platelet</p>
          </def>
        </def-item>
        <def-item>
          <term>PSI</term>
          <def>
            <p>plexins, semaphorins, and integrins</p>
          </def>
        </def-item>
        <def-item>
          <term>SASA</term>
          <def>
            <p>solvent-accessible surface area</p>
          </def>
        </def-item>
        <def-item>
          <term>SNP</term>
          <def>
            <p>single-nucleotide polymorphism</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>
